Legal & General Group
DRIO icon

Legal & General Group’s DarioHealth DRIO Stock Holding History

Legal & General Group’s Portfolio DRIO Stock Details DRIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-54
Closed -$6K – 3559
2022
Q1 		$6K Hold
54
– – ﹤0.01% 3484
2021
Q4 		$14K Hold
54
– – ﹤0.01% 3379
2021
Q3 		$15K Hold
54
– – ﹤0.01% 3360
2021
Q2 		$23K Buy
+54
New +$20.6K ﹤0.01% 3243

Other funds holding DRIO

NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $16.6B AUM 68.34% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $10.5B AUM 49.21% 1-Year Est. Return
CHM
Collaborative Holdings Management New York $49.2M AUM 119.38% 1-Year Est. Return
AWAM
Appian Way Asset Management New York $558M AUM 1.95% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
MCM
MAI Capital Management Independence, Ohio $17.7B AUM 18.87% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Legal & General Group's DRIO Position: Q2 2022 in Review

Legal & General Group sold out of DarioHealth (DRIO) in Q2 2022, closing a stake of 54 shares — an estimated $6K sold.

Legal & General Group first reported a position in DRIO in Q2 2021 and held it in 4 quarters. The position peaked at $23K in Q2 2021. 58 funds tracked by Wall St. Rank hold DRIO as of Q2 2022.

  • Legal & General Group reported no remaining DarioHealth position as of Q2 2022 after selling out during the quarter.
  • Legal & General Group sold 54 DarioHealth shares in Q2 2022, an estimated $6K.
  • Legal & General Group first reported a position in DarioHealth in Q2 2021 and held it in 4 quarters.
  • Legal & General Group's DarioHealth position peaked at $23K in Q2 2021.
  • 58 funds tracked by Wall St. Rank held DarioHealth as of Q2 2022.

Based on Legal & General Group's 13F filing for Q2 2022, filed 22 Aug 2022.